Calamos Advisors’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Calamos Advisors’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-625,000	Closed	-$28.8K	–	1189
2023 Q1	$28.8K	Hold	625,000	–	–	﹤0.01%	975
2022 Q4	$6.56K	Buy	+625,000	New	+$18.8K	﹤0.01%	1130

Calamos Advisors's IQMDW Position: Q2 2023 in Review

Calamos Advisors sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 625,000 shares — an estimated $28.8K sold.

Calamos Advisors first reported a position in IQMDW in Q4 2022 and held it in 2 quarters. The position peaked at $28.8K in Q1 2023. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Calamos Advisors reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Calamos Advisors sold 625,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $28.8K.
Calamos Advisors first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2022 and held it in 2 quarters.
Calamos Advisors's Intelligent Medicine Acquisition Corp. Warrant position peaked at $28.8K in Q1 2023.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.